IVVD Q3 2025 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+41.2% YoY

Gross Profit

$12M91.7% margin

Operating Income

-$11M-84.0% margin

Net Income

-$10M-79.7% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$139M

Total Liabilities

$46M

Stockholders' Equity

$93M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$9M	+41.2%
Gross Profit	$12M	$8M	+41.8%
Operating Income	-$11M	-$62M	+82.3%
Net Income	-$10M	-$61M	+82.8%

Revenue Segments

Product

$13M100%